By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ipsen 

39, rue du Bois Chaland

Evry Cedex    91029  France
Phone: 33-1-608-72600 Fax: 33-1-608-61609


SEARCH JOBS


Industry
Pharmaceutical






Company News
Ipsen (IPN.PA) Strengthens Its Presence In The Oncology Field With The Acquisition Of Octreopharm Sciences, A Company Developing Innovative Radiopharmaceuticals For The Diagnosis And Treatment Of Neuroendocrine Tumors 5/19/2015 11:01:50 AM
Ipsen (IPN.PA) Announces Data Presentations For Somatuline Depot (lanreotide) In Gastroenteropancreatic Neuroendocrine Tumors At ASCO Annual Meeting 5/14/2015 12:35:04 PM
Ipsen (IPN.PA) Reports Strong Sales Growth In Q1 2015 And Raises Guidance For The Year 4/29/2015 12:18:38 PM
Ipsen (IPN.PA), Active Biotech AB (BTPC) Plummet As Prostate Cancer Drug Flunks Late-Stage Trial 4/16/2015 10:23:37 AM
Ipsen (IPN.PA) And Hannover Medical School Start Joint Research In Recombinant Botulinum Neurotoxins For Targeted Secretion Inhibitors 4/8/2015 11:31:34 AM
Ipsen (IPN.PA) Expands Ties To Harvard University With Signing Of A New Research Alliance Agreement 4/2/2015 11:07:49 AM
Ipsen (IPN.PA) Plants R&D Foothold in U.S. at New Mass. Facility 4/1/2015 8:51:30 AM
Lexicon Pharmaceuticals, Inc. (LXRX) And Ipsen (IPN.PA) Expand Their Licensing And Commercialization Agreement For Telotristat Etiprate To Include Canada 3/18/2015 6:50:52 AM
Allergan (AGN) Rival Ipsen (IPN.PA) to Continue U.S. Hiring Spree 3/13/2015 6:55:02 AM
Ipsen (IPN.PA)’s 2014 Results and 2015 Financial Objectives 3/3/2015 11:59:06 AM
12345678910...
//-->